Tristel PLC (TSTL)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
415.00p
Buy
420.00p
-7.50p (-1.76%)
Prices updated at 19 Dec 2025, 16:29 GMT
| Prices minimum 15 mins delay
Prices in GBX
Tristel PLC is a medical instruments manufacturer. Its products include infection prevention and contamination control equipment used in various medical settings.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 42m | 46m | |
| 34m | 37m | |
| 7m | 10m | |
| 16.65 | 21.00 | |
| 6m | 7m | |
| 10m | 11m | |
| Sales, General and administrative | 23m | 25m |
| Interest expenses | 218,000 | 259,000 |
| Provision for income taxes | 593,000 | 2m |
| Operating expenses | 27m | 28m |
| Income before taxes | 7m | 8m |
| Net income available to common shareholders | 6m | 7m |
| 0.129 | 0.1392 | |
| Net interest income | 100,000 | 19,000 |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 0.129 | 0.1383 |
| Free cash flow per share | 0.1819 | 0.1736 |
| Book value/share | 0.6796 | 0.691 |
| Debt equity ratio | 0.149028 | 0.143615 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 25m | 26m |
| Current liabilities | 7m | 7m |
| Total capital | 32m | 33m |
| Total debt | 6m | 6m |
| Total equity | 32m | 33m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 44m | 45m |
| Total liabilities | - | - |
| Cash and cash equivalents | 6m | 9m |
| Common stock | 48m | 48m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 7m | 6m |
| Cash dividends paid | -6m | -7m |
| 9m | 8m | |
| Investments (gains) losses | -5m | -254,000 |
| 6m | 9m | |
| Net income | - | - |
| 11m | 10m | |
| -2m | -2m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.